Indian drugmaker gets US approval to sell generic Lipitor, after delay over quality problems

TRENTON, N.J. - India's largest maker of generic drugs won approval late Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the day. The U.S....More